Le Lézard
Classified in: Health, Covid-19 virus
Subject: ATY

Contact Levi & Korsinsky by August 6, 2024 Deadline to Join Class Action Against Gritstone bio, Inc.(GRTS)


NEW YORK, July 30, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Gritstone investors who were adversely affected by alleged securities fraud between March 9, 2023 and February 29, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/gritstone-lawsuit-submission-form?prid=92693&wire=4

GRTS investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the Company would be unable to launch the Phase 2b CORAL Study, it's approved COVID-19 vaccine, in the timeframe it had represented to investors; (ii) the foregoing would impair Gritstone's ability to obtain external funding in connection with the Study, thereby negatively affecting Gritstone's ability to maintain its balance sheet and cash position; (iii) accordingly, Gritstone overstated its ability to successfully develop and commercialize its products; (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Gritstone during the relevant time frame, you have until August 6, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 02:00
Caledonia Mining Corporation Plc ("Caledonia" or the "Company") announces gold production from the Blanket Mine in Zimbabwe ("Blanket") for the quarter ended September 30, 2024 ("Q3 2024" or the "Quarter"). All production numbers are expressed on a...

14 oct 2024
Report on how AI is driving market transformation - The Global Artificial Intelligence Platforms Market size is estimated to grow by USD 64.9 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  45.1%  during...

14 oct 2024
Report on how AI is driving market transformation - The Global Automation Solutions for Renewable Power Generation Market size is estimated to grow by USD 3.15 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR...

14 oct 2024
Report with market evolution powered by AI - The Global Continuous Positive Airway Pressure (CPAP) Devices Market  size is estimated to grow by USD 1.33 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of...

14 oct 2024
Wall Street icons have long been revered for their groundbreaking philosophies and strategies. Behind their firms' mystique often lies an intense culture of perfectionism, where even minor errors prompt detailed evaluations. In this high-stakes...

14 oct 2024
The International Society for Pharmaceutical Engineering (ISPE) has recognized Eli Lilly Kinsale Limited as the Overall Winner of the 2024 Facility of the Year Awards (FOYA) for its IE2b facility based in Kinsale, Ireland. The winner was announced...



News published on and distributed by: